Prenatal diagnosis tests and women’s risk perception: a cross-sectional study

References

• Zournatzi V, Daniilidis A, Karidas C, et al. A prospective two years study of first trimester screening for Down syndrome. Hippokratia 2008;12:28–32.
   PubMed Web of Science ®Google Scholar
• Vergani P, Locatelli A, Biffi A, et al. Factors affecting the decision regarding amniocentesis in women at genetic risk because of age 35 years or older. Prenat Diagn 2002;22:769–74.
   PubMed Web of Science ®Google Scholar
• Grant S. Options for Down syndrome screening: what will women choose? J Midwifery Womens Health 2005;50:211–8.
   PubMed Web of Science ®Google Scholar
• Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Multicentre randomised clinical trial of Chorion villus sampling and amniocentesis. First report. Lancet 1989;333:1–6.
   Google Scholar
• Van Den Heuvel A, Chitty L, Dormandy E, et al. Will the introduction of noninvasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patients Educ Couns 2010;78:24–8.
   PubMed Web of Science ®Google Scholar
• Lewis C, Silcock C, Chitty LS. Non-invasive prenatal testing for Down's syndrome: pregnant women's views and likely uptake. Public Health Genomics 2013;16:223–32.
   PubMed Web of Science ®Google Scholar
• Aalfs CM, Mollema ED, Oort FJ, et al. Genetic counselling form familial condition during pregnancy: an analysis of patient characteristics. Clin Genet 2004;66:112–21.
   PubMed Web of Science ®Google Scholar
• Marteau TM, Kidd J, Cook R, et al. Perceived risk not actual risk predicts uptake of amniocentesis. Br J Obstet Gynaecol 1991;98:282–6.
   PubMedGoogle Scholar
• Lloyd A, Hayes P, Bell PR, Navlor AR. The role of risk and benefit perception in informed consent for surgery. Med Decis Making 2001;21:141–9.
   PubMed Web of Science ®Google Scholar
• Kahneman D, Tversky A. Subjective probability: a judgment of representativeness. Cog Psychol 1972;3:430–54.
   Web of Science ®Google Scholar
• Gigerenzer G, Edwards A. Simple tools for understanding risks: from innumeracy to insight. BMJ 2003;327:641–4.
   PubMed Web of Science ®Google Scholar
• Caughey AB, Washington AE, Kupperman M. Perceived risk of prenatal diagnostic procedure-related miscarriage and Down syndrome among pregnant women. Am J Obstet Gynecol 2008;198:333.e1–e8.
   PubMed Web of Science ®Google Scholar
• Bakker M, Birnie E, Pajkrt E, et al. Low uptake of the combined test in the Netherlands – Which factors contribute? Prenat Diagn 2012;32:1305–12.
   PubMed Web of Science ®Google Scholar
• Edwards A, Unigwe S, Elwyn G. Effects of communicating individual risks in screening programmes: Cochrane sistematic review. BMJ 2003;327:703–9.
   PubMed Web of Science ®Google Scholar
• Sivell S, Elwiyn G, Gaff CL, et al. How risk is perceived, constructed ed interpreted by clients in clinical genetics, and the effects on decision making: systematic review. J Genet Counsel 2008;17:30–63.
   PubMedGoogle Scholar
• Skjoth MM, Draborg E, Pedersen CD, et al. Providing information about prenatal screening for Down syndrome: a systematic review. Acta Obstet Gynecol Scand 2015;94:125–32.
   PubMed Web of Science ®Google Scholar
• St Jacques S, Grenier S, Charland M, et al. Decisional needs assessment regarding Down syndrome prenatal testing: a systematic review of the perceptions of women, their partners and health professionals. Prenat Diagn 2008;28:1183–203.
   PubMed Web of Science ®Google Scholar
• Keller C, Siegrist M. Effect of risk communication formats on risk perception depending on numeracy. Med Decis Making. 2009;29:483.
   PubMed Web of Science ®Google Scholar
• Kosec V, Zec I, Tislaric-Medenjak D, et al. Pregnat women’s knowledge and attitude to prenatal screening for fetal chromosomal abnormalities: Croatian multicentric survey. Coll Antropl 2013;37:483–9.
   PubMedGoogle Scholar
• Ternby E, Ingvoldstad C, Anneren G, et al. Information and knowledge about Down syndrome among women and partners after first trimester combined testing. AOGS 2015;94:329–32.
   Web of Science ®Google Scholar
• Michie S, Dormandy E, Marteau TM. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns 2002;48:87–91.
   PubMed Web of Science ®Google Scholar
• Bekker H, Hewison J, Thornton J. Applying decision analysis to facilitate informed decision making about prenatal diagnosis for DS: a randomised controlled trial. Prenat Diagn 2004;24:265–7526.
   PubMed Web of Science ®Google Scholar
• Kuppermann M, Learman L, Gates E, et al. Beyond race or ethnicity and socioeconomic status: predictors of prenatal testing for Down syndrome. Obstet Gynecol 2006;107:1087–97.
   PubMed Web of Science ®Google Scholar
• Ekwo E, Seals B, Kim JO, et al. Factors influencing maternal estimates of genetic risk. Am J Med Genet 1985;20:491–504.
   PubMed Web of Science ®Google Scholar
• Pilnick A, Fraser D, James D. Presenting and discussing nuchal translucency screening for fetal abnormality in the UK. Midwifery 2004;20:82–93.
   PubMed Web of Science ®Google Scholar
• Nisihiyama M, Sawai H, Kosugi S. The current state of genetic counseling before and after amniocentesis for fetal karyotiping in Japan: a survey of obstetric hospital clients of a prenatal testing laboratory. J Genet Counsel 2013;22:795–804.
   PubMed Web of Science ®Google Scholar
• Van Schendel RV, Kleinveld JH, Dondorp WJ, et al. Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur J Hum Genet 2014;22:1345–50.
   PubMed Web of Science ®Google Scholar
• Lichtenbelt KD, Schuring-Blom GH, Van der Burg N, et al. Factors determining uptake of invasive testing following first-trimester combined testing. Prenat Diagn 2013;33:328–33.
   PubMed Web of Science ®Google Scholar
• Godino L, Turchetti D, Skirton H. A systematic review of factors influencing uptake of invasive fetal genetic testing by pregnant women of advanced maternal age. Midwifery 2013;29:1235–43.
   PubMed Web of Science ®Google Scholar
• Dormandy E, Michie S, Weinman J, Marteau TM. Variation in uptake of serum screening: the role of service delivery. Prenat Diagn 2002;22:67–9.
   PubMed Web of Science ®Google Scholar